Electroencephalography in emerging viral infections: Lessons learned from implementing an EEG unit in a Lassa fever isolation ward in Nigeria.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Electroencephalography (EEG) has been used for almost a century in well-equipped medical centers to facilitate the diagnosis of epilepsy and other brain disorders. Lassa fever (LF) and other emerging viral infections (EVI) are known to cause neurological complications, including meningitis, seizures, and encephalopathy, though to date it remains unclear whether these are secondary to metabolic disturbances caused by the disease or by direct involvement of the central nervous system (CNS). To better characterize how Lassa virus (LASV) affects the CNS, we established an EEG diagnostic unit in the LF isolation ward at Irrua Specialist Teaching Hospital in Edo State, Nigeria. Here, we report on the specific difficulties to successful implementation of EEG in this highly challenging setting. Technical artefacts due to electrical interferences and interrupted power supply, artefacts deriving from a partly improvised EEG setup within a high consequence pathogen isolation ward, and environmental factors, such as heat in the endemic West African setting are among the main difficulties encountered when setting up this diagnostic facility. It takes experienced neurophysiologists to distinguish such artefacts from actual EEG abnormalities as many of them are not commonly encountered to this extent in well-equipped EEG laboratories and can easily be confused with pathologies. The EEG recording process is further complicated by biosafety considerations and the necessity of wearing extensive personal protective equipment. Nevertheless, with the help of experienced neurophysiologists, it is possible to correctly set up the facility and interpret recordings. Taking the above into consideration, EEG is valuable in identifying CNS involvement in emerging infections, particularly regarding assessment of encephalitis, differential diagnosis of impaired consciousness and treatment adjustment in patients with symptomatic seizures. Although highly challenging under these circumstances, EEG can be an important, noninvasive diagnostic tool for neurological complications in EVI where other more advanced imaging modalities are not available.

Identifiants

pubmed: 39356691
doi: 10.1371/journal.pntd.0012522
pii: PNTD-D-24-00593
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0012522

Informations de copyright

Copyright: © 2024 Mueller et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Hannah Caroline Sophie Mueller (HCS)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Cyril Oshomah Erameh (CO)

Institute of Viral and Emergent Pathogens Control and Research, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Mathias Gelderblom (M)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Osahogie Isaac Edeawe (OI)

Institute of Viral and Emergent Pathogens Control and Research, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Pharmacology and Therapeutics, Ambrose Alli University, Ekpoma, Nigeria.

Osetohamen Grace Akpasubi (OG)

Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Ekpen Uwayeme Ekoyata (EU)

Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Ujiagbe Moses Aiterebhe (UM)

Institute of Viral and Emergent Pathogens Control and Research, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Joseph Okoeguale (J)

Institute of Viral and Emergent Pathogens Control and Research, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Obstetrics and Gynecology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Stephan Guenther (S)

Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research, Partner Sites Hamburg-Lübeck-Borstel-Riems, Germany.

Lisa Oestereich (L)

Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research, Partner Sites Hamburg-Lübeck-Borstel-Riems, Germany.

Michael Ramharter (M)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Center for Infection Research, Partner Sites Hamburg-Lübeck-Borstel-Riems, Germany.

Sylvanus Okogbenin (S)

Institute of Viral and Emergent Pathogens Control and Research, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Obstetrics and Gynecology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Till Omansen (T)

Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research, Partner Sites Hamburg-Lübeck-Borstel-Riems, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH